UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of November 2017
Commission File Number 001-35463
Taro Pharmaceutical Industries Ltd.
(Translation of registrant’s name into English)
14 Hakitor Street, Haifa Bay 2624761, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): _____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _____
CONTENTS
Annexed hereto and incorporated herein by reference are copies of the below materials being furnished by Taro Pharmaceutical Industries Ltd. (the “Company” or “Taro”) to its shareholders in connection with its 2017 annual general meeting of shareholders (the “Meeting”) that is scheduled to be held at the offices of its Israeli counsel, Meitar Liquornik Geva Leshem Tal, located at 16 Abba Hillel Road, 10th Floor, Ramat Gan 5250608, Israel, on Thursday, December 28, 2017, at 10:00 a.m., Israel time.
The Meeting materials consist of the following:
|
1.
|
Exhibit 99.1: Notice and Proxy Statement, each dated November 22, 2017, being mailed to the shareholders of Taro in connection with the Meeting.
|
|
2.
|
Exhibit 99.2: Proxy Card being mailed to shareholders of Taro for use in connection with the Meeting.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 22, 2017
|
|
TARO PHARMACEUTICAL INDUSTRIES LTD.
|
|
|
|
|
|
|
|
|
By:
|
/s/ Uday Baldota
|
|
|
|
|
Name:
|
Uday Baldota
|
|
|
|
|
Title:
|
Chief Executive Officer and Director |
EXHIBIT INDEX